SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ENSC

Ensysce Biosciences Inc.
NASDAQHealth Care

Latest close: 0.52 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 25, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record49015 flagged findings
Reported transactions (Form 4)8since Dec 9, 2022 · and 1 other holding
Corporate events (8-K)30since Oct 24, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-30capital return (buybacks/dividends)recentOpen filing ↗
    “…of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary…”
  • 2026-04-09share offering or dilution eventrecentOpen filing ↗
    “…of preferred stock were initially convertible at a conversion price of $2.50 per common share, subject to adjustment, at the…”
    +1 more passage from the same document
    • “…of fees and offering expenses. 10 On April 6, 2026, pursuant to the Securities Purchase Agreement and a subsequent purchase…”
  • 2026-04-09listing compliance noticerecentOpen filing ↗
    “…On November 14, 2024, we received notice from Nasdaq stating that we had demonstrated compliance with the $2.5 million stockholders’…”
    +1 more passage from the same document
    • “…of our common stock has remained below $1.00 for more than 30 consecutive business days. We have until August 24, 2026, and…”
  • 2026-04-09capital return (buybacks/dividends)recentOpen filing ↗
    “…of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary…”
  • 2026-04-08share offering or dilution eventrecentOpen filing ↗
    “…cause any adjustment of the Conversion Price or the Exercise Price to the extent the holders of Preferred Stock would not be…”
    +1 more passage from the same document
    • “…reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or…”
  • 2026-03-30share offering or dilution eventrecentOpen filing ↗
    “…per share, and is convertible into Common Stock at a conversion price of $2.50 per share, subject to customary anti-dilution…”
    +1 more passage from the same document
    • “…19, 2025. The provisions of the OBBBA became effective for the Company during the three months ended September 30, 2025. The new…”
  • 2026-03-30listing compliance noticerecentOpen filing ↗
    “…de-listing of our common stock on Nasdaq could have a material adverse effect on us, including on our ability to raise capital…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of May 22, 2026).

Open the 8-K at the SEC

Reverse splits in 5 years

3 reverse splits in 5 years (1:20 on Oct 28, 2022, 1:12 on Mar 31, 2023, 1:15 on Dec 6, 2024) · 1:3600 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 490)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 16, 268-K/A ↗Current report · Financial statements and exhibits · amendment new
  • Sep 29, 268-K ↗Current report · Bylaws or fiscal year change
  • Aug 25, 268-K ↗Current report · Other events
  • Aug 24, 268-K ↗Current report · Other events
  • Aug 18, 26SCHEDULE 13D/A ↗Stake with intent to influence · Bob Gene Gower · 6.1% · event on Aug 7, 26 · amendment
  • Aug 18, 26Form 4 ↗Insider transaction
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results
  • Aug 10, 26Form 3 ↗Insider transaction
  • Aug 6, 268-K/A ↗Current report · Financial statements and exhibits · amendment
  • Aug 6, 268-K ↗Current report · Entered a material agreement
  • Jul 15, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 4, 26S-3 ↗Securities offering
  • May 22, 268-K ↗Current report · Listing notice (8-K 3.01)
  • May 15, 2610-Q ↗Quarterly report
  • May 15, 268-K ↗Current report · Results
  • Apr 14, 26CORRESP ↗Correspondence with the SEC
  • Apr 13, 26UPLOAD ↗Correspondence with the SEC
  • Apr 9, 26S-3 ↗Securities offering
  • Apr 8, 268-K ↗Current report · Entered a material agreement
  • Apr 3, 268-K ↗Current report · A senior executive left or was appointed
  • Mar 30, 2610-K ↗Annual report
  • Mar 30, 268-K ↗Current report · Results
  • Mar 30, 268-K ↗Current report · A senior executive left or was appointed
  • Mar 23, 268-K ↗Current report · Bylaws or fiscal year change

490 filings on record, the oldest from Oct 27, 17.

Listing the 25 most recent filings of the 490 on record.

8-Ks, explained

Stress11Structure76Governance12
  • Aug 6, 26StructureEntered a material agreement+7 more in the same filing8-K 1.01 ↗
  • Jul 15, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 22, 26StressListing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Apr 8, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 3, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 30, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 27, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 17, 25StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jun 5, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Apr 24, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 31, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Feb 4, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

7 older filings not shown · The record reaches back to Dec 9, 19.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Aug 23, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Mar 29, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 17, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 31, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Dec 16, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 17, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 1, 21StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • May 14, 21StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 11 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Perceptive Advisors LLC3.7%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Adage Capital Management, L.P.3.1%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Anson Funds Management LP2.1%Dec 31, 24SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 7, 26Buy$198KBOB G GOWER↗
  • Apr 23, 26Buy$246KBOB G GOWER↗
  • Mar 2, 23Buy$44KBOB G GOWER↗
  • Mar 1, 23Buy$129KBOB G GOWER↗
  • Feb 28, 23Buy$53KBOB G GOWER↗
  • Dec 9, 22Buy$500KBOB G GOWER↗

The full record holds 6 transactions and goes back to Dec 9, 22.

Its sector and its market

Ensysce Biosciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Ensysce Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Ensysce Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
490 documents on file, from Oct 27, 2017 to Oct 16, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.